Metronics Introduces Brain-Stimulation Implants
By wchung | 09 Apr, 2026
Medtronic Inc. said Tuesday it began marketing two surgically implanted devices that are intended to help relieve symptoms for patients with neurodegenerative diseases.
The Minneapolis company said it is now marketing the Activa RC and Activa PC neurostimulators in Canada, and the first implantation of the new device has already taken place. The products are intended to reduce symptoms by stimulating the brain electronically.
Medtronic said the devices have new programming options, are smaller than its older models, and feature rechargeable batteries that can last up to nine years before a replacement is needed. The neurostimulators are used to treat conditions like Parkinson’s disease and tremors.
In afternoon trading, Medtronic shares added 65 cents to $43.09.
2/16/2010 1:30 PM NEW YORK (AP)
Recent Articles
- 'Ghost Murmur' Used to Locate Downed Airman Was Trump's Bogus Reference to an Actual Technology
- House GOP Blocks Bid to Curtail Trump War Powers
- What Molecule Protects Your Brain, Fights Stress and Boosts Athletic Performance?
- Tesla Developing Smaller Cheaper EV
- Amazon Cloud Unit AI Revenue Exceeds $15 Billion on Annualized Basis
- List of Major AI Infrastructure Deals to Meet Booming Demand
- Mercedes Suffers Down Q1 on Plunging China Sales
- Intel and Google Expand Partnership to Address Demand for Versatile CPUs
- Chip Designer SiFive Raises $400 Million from Atreides, Nvidia to Step into Arm's Space
- Samsung Electronics Mulls Chip Testing and Packaging in Vietnam